A detailed history of Monashee Investment Management LLC transactions in Xencor Inc stock. As of the latest transaction made, Monashee Investment Management LLC holds 80,000 shares of XNCR stock, worth $1.65 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares
80,000
Holding current value
$1.65 Million
% of portfolio
0.21%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$15.7 - $21.65 $1.26 Million - $1.73 Million
80,000 New
80,000 $1.61 Million
Q2 2018

Aug 10, 2018

SELL
$28.41 - $42.41 $6.82 Million - $10.2 Million
-240,000 Closed
0 $0
Q1 2018

May 10, 2018

BUY
$21.18 - $33.78 $5.08 Million - $8.11 Million
240,000 New
240,000 $7.2 Million

Others Institutions Holding XNCR

About Xencor Inc


  • Ticker XNCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,698,100
  • Market Cap $1.23B
  • Description
  • Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...
More about XNCR
Track This Portfolio

Track Monashee Investment Management LLC Portfolio

Follow Monashee Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Monashee Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Monashee Investment Management LLC with notifications on news.